The use of an implantable cardioverter defibrillator in a boxer dog to control clinical signs of arrhythmogenic right ventricular cardiomyopathy

Journal of Veterinary Internal Medicine

Volumn 20, Issue 5, 2006, Pages 1232-1237

  Nelson, O Lynne ^a   Lahmers, Sunshine ^a   Schneider, Terri ^a   Thompson, Pam ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; CASE REPORT; DEFIBRILLATOR; DOG; DOG DISEASE; FATALITY; HEART RIGHT VENTRICLE DYSPLASIA; MALE; PATHOLOGY; POSTOPERATIVE COMPLICATION;

ANIMALS; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; DEFIBRILLATORS, IMPLANTABLE; DOG DISEASES; DOGS; FATAL OUTCOME; MALE; POSTOPERATIVE COMPLICATIONS;

CANIS FAMILIARIS;

EID: 33750298139     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2006)20[1232:TUOAIC]2.0.CO;2     Document Type: Article

References (21)

1. Baumwart RD, Meurs KM, Atkins CE, et al. Clinical, echocardiographic and electrocardiographic abnormalities in boxers with cardiomyopathy and left ventricular systolic dysfunction: 48 cases (1985-2003). J Am Vet Med Assoc 2005;226:110-1104.
2. Meurs KM, Spier AW, Wright NA, et al. Comparison of the effects of four antiarrhythmic treatments for familial ventricular arrhythmias in Boxers. J Am Vet Med Assoc 2002;221:522-527.
3. Moise SN. Pacemaker therapy. In: Fox PR, Sisson D, Moise SN, eds. Textbook of Canine and Feline Cardiology, 2nd ed. Philadelphia, PA: WB Saunders; 1999:400-425.
4. Sisson D, Thomas WP, Woodfield J, et al. Permanent transvenous pacemaker implantation in forty dogs. J Vet Intern Med 1991;5:322-331.
5. Harpster N. Boxer cardiomyopathy. In: Kirk RW, ed. Current Veterinary Therapy VIII. Philadelphia, PA: WB Saunders; 1983:329-337.
6. Meurs KM, Spier AW, Miller MW, et al. Familial ventricular arrhythmias in boxers. J Vet Intern Med 1999;13:437-439.
7. Basso C, Fox FR, Meurs KM, et al. Arrhythmogenic right ventricular cardiomyopathy causing sudden cardiac death in Boxer Dogs: A new animal model of human disease. Circulation 2004;109:1180-1185.
8. Dalai D, Nasir K, Bomma C, et al. Arrhythmogenic right ventricular dysplasia: A United States experience. Circulation 2005;112:3823-3832.
9. Harpster N. Boxer cardiomyopathy. A review of the long term benefits of antiarrhythmic therapy. Vet Clin North Am Small Anim Pract 1991;21:989-1004.
10. Breithardt G, Wichter T, Haverkamp W, et al. Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, or no structural heart disease. Am Heart J 1994;127:1151-1158.
11. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-1040.
12. Fogoros RN, Elson JJ, Bonnet CA, et al. Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease. J Am Coll Cardiol 1990;16:381-386.
13. Piccini JP, Dalal D, Roguin A, et al. Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. Heart Rhythm 2005;2:1188-1194.
14. O'Callaghan PA, Ruskin JN. The implantable cardioverter defibrillator. In: Fuster V, ed. Hurst's the Heart, 10th ed. New York, NY: McGraw-Hill; 2001:945-962.
15. Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980;303:322-324.
16. Mirowski M, Mower MM, Staewen WS, et al. Standby automatic defibrillator: An approach to prevention of sudden cardiac death. Arch Intern Med 1970;126:158-161.
17. Smith TW, Chen J, Epstein LM. Implantable devices for the treatment of cardiac arrhythmia. In: Baim DS, Grossman W, eds. Grossman's Cardiac Catheterization, Angiography, and Intervention, 6th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2000:489-543.
18. Schaumann A, von zur Muhlen F, Herse B, et al. Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: A prospective study including 200 patients. Circulation 1998;97:66-74.
19. Grimm W, Flores BF, Marchlinski FE. Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 1992;15:1667-1673.
20. Poole JE, Bardy GH, Kudenchuk PJ, et al. Prospective randomized comparison biphasic waveform tilt using a unipolar defibrillation system. Pacing Clin Electrophysiol 1995;18:1369-1373.
21. Fotuhi PC, Epstein AE, Ideker RE. Energy levels for defibrillation: What is of real clinical importance? Am J Cardiol 1999;83:24D-33D.